Nerve-Langerhans cell interactions in diabetes and aging

Area of Science:

• Immunology
• Dermatology
• Endocrinology

Background:

• Cutaneous infections are a major cause of hospitalization for diabetic patients.
• Langerhans cells (LCs) are critical for skin immunity, but diabetes and aging effects are poorly understood.
• Diabetic complications often involve impaired wound healing and increased infection susceptibility.

Purpose of the Study:

• To investigate the impact of diabetes and aging on Langerhans cells (LCs) in rat footpads.
• To determine if diabetes affects LC maturation, proliferation, and relationship with cutaneous innervation.
• To understand how diabetes-induced changes in LCs contribute to skin pathologies.

Main Methods:

• Induction of diabetes in rats using streptozotocin.
• Age-matched control and diabetic rats examined at 3 and 6 months of age.
• Immunostaining for LCs (protein langerin) and neuronal markers (PGP9.5) in footpad skin.

Main Results:

• LC numbers and size increased with age in control rats, indicating maturation.
• Diabetes reduced LC numbers and impaired the age-related increase in LC size.
• Diabetes did not affect cutaneous axon density, but LCs expressing neuronal markers complicated counts.
• LC proliferation and maturation were significantly impacted by diabetes, independent of innervation changes.

Conclusions:

• Diabetes substantially impairs Langerhans cell proliferation and maturation.
• Age-related LC maturation is hindered by diabetes.
• These diabetes-induced LC alterations may predispose individuals to cutaneous infections and ulcers.